May 29, 2026
Gene
Researchers from NYU Langone Health and the NYU Grossman School of Medicine have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive diagnostic tool has the potential to improve patient outcomes by enabling timely intervention.